- Home
- INHD vs BOLT Comparison
INHD vs BOLT Comparison
Compare INHD & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INHD
- BOLT
- Stock Information
- Founded
- INHD 2019
- BOLT 2015
- Country
- INHD United States
- BOLT United States
- Employees
- INHD N/A
- BOLT N/A
- Industry
- INHD
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- INHD
- BOLT Health Care
- Exchange
- INHD Nasdaq
- BOLT Nasdaq
- Market Cap
- INHD 19.8M
- BOLT 16.8M
- IPO Year
- INHD 2023
- BOLT 2021
- Fundamental
- Price
- INHD $1.32
- BOLT $0.32
- Analyst Decision
- INHD
- BOLT Buy
- Analyst Count
- INHD 0
- BOLT 3
- Target Price
- INHD N/A
- BOLT $2.50
- AVG Volume (30 Days)
- INHD 2.8M
- BOLT 812.4K
- Earning Date
- INHD 05-02-2025
- BOLT 05-12-2025
- Dividend Yield
- INHD N/A
- BOLT N/A
- EPS Growth
- INHD N/A
- BOLT N/A
- EPS
- INHD N/A
- BOLT N/A
- Revenue
- INHD $1,559,595.00
- BOLT $3,638,000.00
- Revenue This Year
- INHD N/A
- BOLT N/A
- Revenue Next Year
- INHD N/A
- BOLT $97.29
- P/E Ratio
- INHD N/A
- BOLT N/A
- Revenue Growth
- INHD 287.83
- BOLT N/A
- 52 Week Low
- INHD $1.11
- BOLT $0.27
- 52 Week High
- INHD $19.78
- BOLT $0.78
- Technical
- Relative Strength Index (RSI)
- INHD 32.33
- BOLT 48.17
- Support Level
- INHD $1.22
- BOLT $0.29
- Resistance Level
- INHD $1.54
- BOLT $0.33
- Average True Range (ATR)
- INHD 0.16
- BOLT 0.04
- MACD
- INHD 0.11
- BOLT 0.00
- Stochastic Oscillator
- INHD 36.21
- BOLT 31.19
About INHD Inno Holdings Inc.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.